© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
September 14, 2020
Rheumatologists and OB-GYNs must communicate openly with each other and to patients with rheumatic diseases who are considering pregnancy.
Which composite measures detect the highest level of changes in psoriatic disease activity.
September 12, 2020
When a rheum patient might need to consult with a dermatologist.
September 11, 2020
Filgotinib was well-tolerated and sustained efficacy in a 52-week extension study.
September 10, 2020
According to a poster presented at CCR East 2020, patients
July 21, 2020
Upadacitinib 15 mg and 30 mg outperformed placebo in Measure Up 2, the second part of a phase 3 study on the monotherapy.
July 14, 2020
Guselkumab represents the first FDA approved medication for active psoriatic arthritis that selectively inhibits interleukin-23.
July 01, 2020
The statement contains positions and oppositions for telemedicine, along with highlights barriers and opportunities for patients and rheumatology professionals.
June 11, 2020
Dr. Vibeke Strand discusses the relationship between COVID-19 and psoriatic arthritis.
Dr. Vibeke Strand discusses how better treatment of psoriatic arthritis could yield better treatments for NASH.